Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death

European Journal of Pharmacology

Volumn 562, Issue 3, 2007, Pages 174-182

  Rabkin, Simon W ^a   Klassen, Shaun S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adrenomedullin; Cardiomyocyte cell death; Cyanide antimycin A; Cytochrome c; Mitochondrial transmembrane potential; Omapatrilat

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADRENOMEDULLIN; ANTIMYCIN A1; CYTOCHROME C; DEOXYGLUCOSE; LISINOPRIL; OMAPATRILAT; POTASSIUM CYANIDE; PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ELECTRON TRANSPORT; EMBRYO; FLUORESCENCE MICROSCOPY; GLYCOLYSIS; HEART MUSCLE CELL; HEART PROTECTION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

ADRENOMEDULLIN; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIMYCIN A; CARDIOTONIC AGENTS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; CYTOCHROMES C; DEOXYGLUCOSE; DRUG SYNERGISM; ELECTRON TRANSPORT; LISINOPRIL; MEMBRANE POTENTIALS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION; POTASSIUM CYANIDE; PYRIDINES; THIAZEPINES;

EID: 34147183397     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.056     Document Type: Article

References (54)

1. Adams J.M. Ways of dying: multiple pathways to apoptosis. Genes Dev. 17 (2003) 2481-2495
2. Backlund T., Palojoki E., Saraste A., Gronholm T., Eriksson A., Lakkisto P., Vuolteenaho O., Nieminen M.S., Voipio-Pulkki L.M., Laine M., and Tikkanen I. Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Cardiovasc. Res. 57 (2003) 727-737
3. Botla R., Spivey J.R., Aguilar H., Bronk S.F., and Gores G.J. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J. Pharmacol. Exp. Ther. 272 (1995) 930-938
4. Cataliotti A., Boerrigter G., Chen H.H., Jougasaki M., Costello L.C., Tsuruda T., Lee S.C., Malatino L.S., and Burnett Jr. J.C. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure. Circulation 105 (2002) 639-644
5. Di Lisa F., Blank P.S., Colonna R., Gambassi G., Silverman H.S., Stern M.D., and Hansford R.G. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J. Physiol. 486 Pt 1 (1995) 1-13
6. Dussmann H., Rehm M., Kogel D., and Prehn J.H. Outer mitochondrial membrane permeabilization during apoptosis triggers caspase-independent mitochondrial and caspase-dependent plasma membrane potential depolarization: a single-cell analysis. J. Cell Sci. 116 (2003) 525-536
7. Engelbrecht A.M., Niesler C., Page C., and Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res. Cardiol. 99 (2004) 338-350
8. Erdos E.G., and Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 3 (1989) 145-151
9. Eto T., Kato J., and Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regulatory Pept. 112 (2003) 61-69
10. Hasin Y., Doorey A., and Barry W.H. Electrophysiologic and mechanical effects of metabolic inhibition of high-energy phosphate production in cultured chick embryo ventricular cells. J. Mol. Cell. Cardiol. 16 (1984) 1009-1021
11. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21 (2000) 138-167
12. Jiang S., Cai J., Wallace D.C., and Jones D.P. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved. J. Biol. Chem. 274 (1999) 29905-29911
13. Jiang W., Jiang H.F., Pan C.S., Cai D.Y., Qi Y.F., Pang Y.Z., and Tang C.S. Relationship between the contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of spontaneously hypertensive rats. Hypertens. Res. 7 (2004) 109-117
14. Jougasaki M., Wei C.M., McKinley L.J., and Burnett Jr. J.C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92 (1995) 286-289
15. Kato H., Shichiri M., Marumo F., and Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138 (1997) 2615-2620
16. Kato K., Yin H., Agata J., Yoshida H., Chao L., and Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. 285 (2003) H1506-H1514
17. Kaushal G.P., Ueda N., and Shah S.V. Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. Kidney Int. 52 (1997) 438-445
18. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
19. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192 (1993) 553-560
20. Kong J.Y., and Rabkin S.W. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim. Biophys. Acta 1485 (2000) 45-55
21. Kong J.Y., and Rabkin S.W. Mitochondrial effects with ceramide-induced cardiac apoptosis are different from those of palmitate. Arch. Biochem. Biophys. 412 (2003) 196-206
22. Kong J.Y., Klassen S.S., and Rabkin S.W. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol. Cell. Biochem. 278 (2005) 39-51
23. Kostin S., Pool L., Elsasser A., Hein S., Drexler H.C., Arnon E., Hayakawa Y., Zimmermann R., Bauer E., Klovekorn W.P., and Schaper J. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92 (2003) 715-724
24. Kroemer G. Mitochondrial control of apoptosis: an introduction. Biochem. Biophys. Res. Commun. 304 (2003) 433-435
25. Kuwasako K., Cao Y.N., Nagoshi Y., Kitamura K., and Eto T. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides 25 (2004) 2003-2012
26. Lapointe N., Blais Jr. C., Adam A., Parker T., Sirois M.G., Gosselin H., Clement R., and Rouleau J.L. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. J. Am. Coll. Cardiol. 39 (2002) 1692-1698
27. Lewis L.K., Smith M.W., Brennan S.O., Yandle T.G., Richards A.M., and Nicholls M.G. Degradation of human adrenomedullin (1-52) by plasma membrane enzymes and identification of metabolites. Peptides 18 (1997) 733-739
28. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., and Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278 (2003) 8516-8525
29. Lisy O., Jougasaki M., Schirger J.A., Chen H.H., Barclay P.T., and Burnett Jr. J.C. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin. Am. J. Physiol. 275 (1998) F410-F414
30. Ly J.D., Grubb D.R., and Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8 (2003) 115-128
31. Maniu C.V., Meyer D.M., and Redfield M.M. Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension. Hypertension 40 (2002) 528-534
32. Martinez A., Vos M., Guedez L., Kaur G., Chen Z., Garayoa M., Pio R., Moody T., Stetler-Stevenson W.G., Kleinman H.K., and Cuttitta F. The effects of adrenomedullin overexpression in breast tumor cells. J. Nat. Cancer Inst. 94 (2002) 1226-1237
33. Mathur A., Hong Y., Kemp B.K., Barrientos A.A., and Erusalimsky J.D. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc. Res. 46 (2000) 126-138
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
35. Nieminen A.L. Apoptosis and necrosis in health and disease: role of mitochondria. Int. Rev. Cyt. 224 (2003) 29-55
36. Oehler M.K., Norbury C., Hague S., Rees M.C., and Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 20 (2001) 2937-2945
37. Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K., Tsukamoto Y., Ishibashi-Ueda H., Miwa S., Tambara K., Toyokuni S., Yutani C., and Kangawa K. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109 (2004) 242-248
38. Prabhakaran K., Li L., Borowitz J.L., and Isom G.E. Cyanide induces different modes of death in cortical and mesencephalon cells. J. Pharmacol. Exp. Ther. 303 (2002) 510-519
39. Rabkin S.W., and Kong J.Y. Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. Am. J. Physiol. 279 (2000) H3089-H3100
40. Regula K.M., Ens K., and Kirshenbaum L.A. Mitochondria-assisted cell suicide: a license to kill. J. Mol. Cell. Cardiol. 35 (2003) 559-567
41. Robl J.A., Sun C.Q., Stevenson J., Ryono D.E., Simpkins L.M., Cimarusti M.P., Dejneka T., Slusarchyk W.A., Chao S., Stratton L., Misra R.N., Bednarz M.S., Asaad M.M., Cheung H.S., Abboa-Offei B.E., Smith P.L., Mathers P.D., Fox M., Schaeffer T.R., Seymour A.A., and Trippodo N.C. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J. Med. Chem. 40 (1997) 1570-1577
42. Romppanen H., Marttila M., Magga J., Vuolteenaho O., Kinnunen P., Szokodi I., and Ruskoaho H. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 138 (1997) 2636-2639
43. Sata M., Kakoki M., Nagata D., Nishimatsu H., Suzuki E., Aoyagi T., Sugiura S., Kojima H., Nagano T., Kangawa K., Matsuo H., Omata M., Nagai R., and Hirata Y. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 36 (2000) 83-88
44. Shimokubo T., Sakata J., Kitamura K., Kangawa K., Matsuo H., and Eto T. Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high-salt diet. Clin. Exp. Hypertens. 18 (1996) 949-961
45. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele Jr. G.D., and Chen L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3671-3675
46. Sumimoto T., Nishikimi T., Mukai M., Matsuzaki K., Murakami E., Takishita S., Miyata A., Matsuo H., and Kangawa K. Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 30 (1997) 741-745
47. Tokudome T., Horio T., Yoshihara F., Suga S., Kawano Y., Kohno M., and Kangawa K. Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinology 143 (2002) 3515-3521
48. Totsune K., Takahashi K., Mackenzie H.S., Murakami O., Arihara Z., Sone M., Mouri T., Brenner B.M., and Ito S. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin. Sci. (Lond.) 99 (2000) 541-546
49. Watanabe H., Kuhne W., Spahr R., Schwartz P., and Piper H.M. Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am. J. Physiol. 260 (1991) H1344-H1352
50. Webster K.A., Discher D.J., and Bishopric N.H. Regulation of fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes. Circ. Res. 74 (1994) 679-686
51. Wolvetang E.J., Johnson K.L., Krauer K., Ralph S.J., and Linnane A.W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339 (1994) 40-44
52. Yin H., Chao L., and Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 43 (2004) 109-116
53. Yoshino T., Kishi H., Nagata T., Tsukada K., Saito S., and Muraguchi A. Differential involvement of p38 MAP kinase pathway and Bax translocation in the mitochondria-mediated cell death in TCR- and dexamethasone-stimulated thymocytes. Eur. J. Immunol. 31 (2001) 2702-2708
54. Zhou M., Chaudry I.H., and Wang P. Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis. Biochim. Biophys. Acta 1453 (1999) 273-283